SEC Form 4 · accession 0001053369-15-000034
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerry Treppel
Officer — Chairman of Board · Director
Period of report
Nov 13, 2015
Accepted (ET)
Nov 18, 2015 · 6:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 13, 2015 | G | 7,500 | $0.31 | D | 9,346,769 | D | |
| Common Stock | Nov 13, 2015 | S | 50,000 | $0.30 | D | 9,296,769 | D | |
| Common Stock | Nov 16, 2015 | S | 50,000 | $0.3025 | D | 9,246,769 | D | |
| Common Stock | Nov 17, 2015 | S | 25,000 | $0.3001 | D | 9,221,769 | D | |
| Common Stock | Nov 18, 2015 | S | 25,000 | $0.305 | D | 9,196,769 | D |
Table II — derivative securities
No Table II lines on this filing.